NuVasive Opens Operations in Tokyo
San Diego, Calif.-based spine surgery device company NuVasive Inc. has opened a new facility in Tokyo, Japan. The location will focus on bringing spine products to Japan, which is the second largest spine market in the world.
Takaaki Tanaka, NuVasive’s executive vice president of the Asia-Pacific region will head the Tokyo operations. Tanaka has been with the company since 2009, and brings 20 years of experience in the spine industry.
“NuVasive’s formal presence in Tokyo is a testament to our commitment to surgeon customers and their patients in Japan,” said Tanaka. “We look forward to improving patient outcomes with superior clinical results as we further introduce XLIF and our comprehensive spine portfolio to the Japanese market.”
NuVasive recently completed several of the first Extreme Lateral Interbody Fusion (XLIF) surgical procedures in key cities and markets as a minimally disruptive option for lumbar spine fusion to patients and surgeons in Japan.
“This marks an exciting moment in NuVasive history,” said Alex Lukianov, chairman and CEO of the company. “I am especially pleased to formally open our Tokyo office. As a company, we bring a wealth of experience in spine, with proprietary innovative procedures like XLIF and procedurally integrated solutions. Our initial reception in Japan has been exceptional, and I look forward to working with Tanaka-san and Russell Powers, our executive vice president of international, to improve spine surgery in one of the world’s largest spine markets.”
According to the company, XLIF is a minimally disruptive surgical procedure performed through the side of the body that uses proprietary neuromonitoring and an integrated portfolio of instruments and specialized implants for treating a range of spinal pathologies.
NuVasive’s principal offering is the MAS (Maximum Access Surgery) platform, upon which the XLIF technology is built. According to officials, the MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon.